+987.9%
MRNA vs ENTG
+63.3%
+924.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ENTG | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -6.5% | +19.6% | +13.8% |
| 7D | +20.6% | -10.3% | +31.0% | +21.9% |
| 30D | +27.1% | -14.4% | +41.5% | +28.5% |
| 3M | +353.4% | -1.1% | +354.5% | +350.9% |
| 6M | +446.3% | +3.0% | +443.3% | +402.6% |
| YTD | +776.2% | +70.1% | +706.1% | +527.4% |
| 1Y | +987.9% | +65.7% | +922.2% | +682.9% |
| All | +987.9% | +63.3% | +924.6% | +682.9% |
Cumulative growth
Daily Returns
Daily percentage return beside ENTG.
Daily Out/Under-Performance
Portfolio return minus ENTG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ENTG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ENTG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling